Science

Mitral valve thrombosis after TMVR: where do we stand?

Best way to manage is still unclear, but routine anticoagulation and close follow-up seem warranted.

Share
Clinical research at the dawn of the new decade: what’s next?

Emerging innovation will radically improve clinical trials, with immense benefit for healthcare and society. How will it affect you?

Share
TMVR early experience: first systematic review

TMVR meta-analysis shows technical success, MR resolution, high mid term complications. Enhanced patient selection and less invasive access may favor adoption.

Share
Cardiovascular Innovation – Industry Meets Academia in Zurich

From the operating room to the acceleration of start-ups: a talk with Prof. Francesco Maisano, Chair of Cardiovascular Surgery at University Hospital of Zurich.

Share
Neovasc Reducer for refractory angina relief is recognized by ESC

Reducer is the only non-pharmaceutical treatment included in the “Major New Recommendations” section of the 2019 ESC Clinical Practice Guidelines.

Share
Tendyne TMVR: One Year Predictors of Therapeutic Benefit

Which patients will benefit from transcatheter valve replacement? A recent article reveals a solution for a therapeutic gap in this population.

Share
Women on the Rise in Swiss Startups

Occlufit CEO Dr. Monica Tocchi is one of the 100 female bosses in Switzerland featured by startupticker.ch.

Share
AATS Quality Assessment Program for the 21st Century

AATS has announced the launch of a new live, dynamic, interactive technology data platform to generate innovative real time analyses.

Share
Brain Stimulation to Fight Obesity: Breakthrough Findings

Published in DOM the first randomized study of Deep Transcranial Magnetic Stimulation for the treatment of obesity.

Share